Skip to main content

Peer Review reports

From: Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway

Original Submission
23 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 May 2022 Reviewed Reviewer Report
13 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Author responded Author comments - Jian-sheng Li
Resubmission - Version 3
1 Jul 2022 Submitted Manuscript version 3
8 Jul 2022 Author responded Author comments - Jian-sheng Li
Resubmission - Version 4
8 Jul 2022 Submitted Manuscript version 4
4 Aug 2022 Reviewed Reviewer Report
10 Aug 2022 Reviewed Reviewer Report
23 Aug 2022 Author responded Author comments - Jian-sheng Li
Resubmission - Version 5
23 Aug 2022 Submitted Manuscript version 5
19 Sep 2022 Author responded Author comments - Jian-sheng Li
Resubmission - Version 6
19 Sep 2022 Submitted Manuscript version 6
Publishing
26 Sep 2022 Editorially accepted
22 Nov 2022 Article published 10.1186/s12890-022-02191-9

You can find further information about peer review here.

Back to article page